{'IRON': 'FDA Priority Review for Bitopertin Accelerated Approval', 
 'NVTS': 'New Products for Nvidia’s AI Factory Architecture', 
 'ABVX': 'Phase 3 Success for Obefazimod in Ulcerative Colitis', 
 'LAES': 'Major Partnerships and $200M Capital Raise For Quantum Security', 
 'QURE': 'Positive Huntington’s Disease Therapy Data', 
 'CDTX': 'FDA's Breakthrough Therapy Tag for CD388 in Influenza'}